Your browser is unsupported

Please visit this URL to review a list of supported browsers.

From defining the future of medical technology to researching cures for diseases and changing the way health insurance is delivered, the healthcare companies listed on the New York Stock Exchange are shaping the future of their industry. While they’re on the front lines, our role is behind the scenes; it’s to support this group of innovators and problem solvers by providing the access to capital and other resources public companies need to solve real-world challenges and make a positive impact on their communities. Every year, more healthcare companies turn to us because they know we provide the support they need to launch and manage a public company. Now it’s your turn.

The brightest is yet to come

Why Healthcare Chooses the NYSE


Unique Market Model

Healthcare sector stocks are 56% more volatile than all other industries, which makes the NYSE market model particularly valuable. Through the support of a Designated Market Maker who personally participates in the trading of your stock, our market model lowers your stock’s volatility and increases liquidity.

Unmatched Network

We’re proud to partner with companies that are transforming the future of healthcare. Our network accounts for 71% of the healthcare vertical by market cap and includes companies of all sizes such as Pfizer, J&J, Penumbra, Teladoc, Glaukos, Invitae, Biohaven and Alto Neuroscience.

Brand Visibility

Whether it’s Arcus Biosciences ringing the NYSE Bell, Penumbra sharing their story via 35 live broadcasts from the trading floor, or a campaign getting exposure through our social channels, we offer global visibility with real business results. Our companies leverage NYSE’s unique marketing assets to raise brand visibility, reposition, and support product launches, in addition to using our state-of-the-art conference facilities to host analyst days, conduct board meetings and more.

Investor Relations Services

Being a public company offers increased access to the capital you need to continue innovating and growing, while also placing new demands on your company. We’ve worked closely with the management teams at NYSE-listed companies to understand their needs and develop efficient solutions that address the needs of their growing public businesses.

Unique Market Model

Healthcare sector stocks are 56% more volatile than all other industries, which makes the NYSE market model particularly valuable. Through the support of a Designated Market Maker who personally participates in the trading of your stock, our market model lowers your stock’s volatility and increases liquidity.

Unmatched Network

We’re proud to partner with companies that are transforming the future of healthcare. Our network accounts for 71% of the healthcare vertical by market cap and includes companies of all sizes such as Pfizer, J&J, Penumbra, Teladoc, Glaukos, Invitae, Biohaven and Alto Neuroscience.

Brand Visibility

Whether it’s Arcus Biosciences ringing the NYSE Bell, Penumbra sharing their story via 35 live broadcasts from the trading floor, or a campaign getting exposure through our social channels, we offer global visibility with real business results. Our companies leverage NYSE’s unique marketing assets to raise brand visibility, reposition, and support product launches, in addition to using our state-of-the-art conference facilities to host analyst days, conduct board meetings and more.

Investor Relations Services

Being a public company offers increased access to the capital you need to continue innovating and growing, while also placing new demands on your company. We’ve worked closely with the management teams at NYSE-listed companies to understand their needs and develop efficient solutions that address the needs of their growing public businesses.

Options for Listing at NYSE

Here are the top ways you can access public markets. Each offers a unique path based on your company's needs.

All ways to list

Listings Resources


Supporting Healthcare Innovation

NYSE provides an on-ramp to the public markets for innovative, healthcare companies.

For companies qualified to take part in this program:

  • NYSE will provide fee relief for the first three years of listing
  • Annual fees are calculated and billed quarterly for 12 quarters, at a rate of one-fourth of the applicable annual fee